The Steve Gleason Institute for Neuroscience
Easing the burden of neurodegenerative disease
Americans suffering from ALS and other debilitating neurodegenerative diseases face a grim reality: Few treatments are available to ease symptoms, and there is no cure. Progressive loss of motor and mental function leads to disability and eventually death, placing a heavy burden on patients and family caregivers. The incidence of neurodegenerative disease is expected to soar as the population ages, increasing the urgency to expand treatment options, develop care innovations and ultimately find a cure.
The Steve Gleason Institute for Neuroscience will take an integrated approach to research and care:
Clinical Research and Care Unit
One-stop integrated care and clinical research will:
- Enable patients to see providers from many disciplines in one visit
- Accelerate the translation of research from bench to bedside
- Reduce caregiver burden
Interactive Home and Assistive Technology
Assistive technology will be incorporated into smart homes used as short-stay lodging for patients and families. The homes will also serve as a test site for future technology.
Discovery Research Unit
Founding Director: Marcos Frank, Ph.D.
Professor and Chair, Department of Biomedical Sciences
Elson S. Floyd College of Medicine
Discovery research will help:
- Uncover new biomarkers of disease to improve detection
- Slow disease progression and restore function
- Develop therapies to stop or reverse the disease
Support the Gleason Institute
Do you want to contribute to the Gleason Institute? Contact Brooke Ledeboer, Director of Development at WSU Health Sciences Spokane, at email@example.com or 509-324-7202.